The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-2-(4-fluorophenyl)-N-methyl-2-(5-methyl-3-(pyridin-2-yl)pyrazolo[1,5-a]pyrimidin-7-ylamino)acetamide ID: ALA5181574
PubChem CID: 168277952
Max Phase: Preclinical
Molecular Formula: C21H19FN6O
Molecular Weight: 390.42
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)C(Nc1cc(C)nc2c(-c3ccccn3)cnn12)c1ccc(F)cc1
Standard InChI: InChI=1S/C21H19FN6O/c1-13-11-18(27-19(21(29)23-2)14-6-8-15(22)9-7-14)28-20(26-13)16(12-25-28)17-5-3-4-10-24-17/h3-12,19,27H,1-2H3,(H,23,29)
Standard InChI Key: UWDFNWVULHDPTB-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
-2.6187 3.3601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9041 3.7724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1922 3.3606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1922 2.5353 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9023 2.1236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6187 2.5316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9023 1.2984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2351 0.8136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4899 0.0291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3147 0.0291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5695 0.8136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4306 0.9841 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1215 0.3711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1302 -0.4099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9354 -0.5862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1489 -1.3827 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5656 -1.9659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7792 -2.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2308 -1.7524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1960 -3.3456 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5758 -2.9759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7892 -3.7724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4444 -0.9558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2387 -0.7438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8221 -1.3271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6112 -2.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8163 -2.3381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6187 -1.1136 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.9181 0.5846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
5 7 1 0
8 7 2 0
8 9 1 0
9 10 1 0
10 11 2 0
11 7 1 0
8 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
9 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
17 19 1 0
18 20 2 0
18 21 1 0
21 22 1 0
23 19 2 0
24 23 1 0
25 24 2 0
26 25 1 0
27 26 2 0
19 27 1 0
25 28 1 0
13 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.42Molecular Weight (Monoisotopic): 390.1604AlogP: 3.14#Rotatable Bonds: 5Polar Surface Area: 84.21Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.17CX LogP: 2.14CX LogD: 2.14Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.55Np Likeness Score: -1.82
References 1. Burley R, Hewer RC, Teall M, Dickson L, Ossola B, Russell S, Bender C, Cheung T, Powell JAC, Xu X, Brice NL, Otter L, Arimont M, Kidd SL, Vidal D, Dale JW, Mervin L, Sore HF, Mateu N, Lakshminarayana N, Dawson LA, Carlton M, Bürli RW.. (2022) Synthesis and SAR of novel GPR39 agonists and positive allosteric modulators., 61 [PMID:35123006 ] [10.1016/j.bmcl.2022.128607 ]